◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › IMDX

Insight Molecular Diagnostics Inc. (IMDX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-07-09

Insight Molecular Diagnostics Inc. (IMDX) operates in the Diagnostics & Research industry and is headquartered in Nashville, United States with about 55 employees. Its market capitalization is roughly $158 million. In the fiscal year ended 2025-12-31, IMDX reported $4M in revenue and ($50M) in net income.

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests.

Interactive charts & full statements → Open the IMDX valuation workbench →

IMDX Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$4M$2M$2M$1M
Gross Profit$2M$1M$0M$0M
Operating Income (EBIT)($31M)($23M)($22M)($29M)
Net Income($50M)($61M)($28M)($73M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMDX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$1M$0M$0M$2M
Gross Profit$0M$0M$0M$0M$1M
Operating Income (EBIT)($10M)($10M)($8M)($7M)($6M)
Net Income($4M)($23M)($11M)($10M)($7M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMDX Free Cash Flow History

IMDX Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$26M$35M$75M$100M
Total Liabilities$57M$47M$54M$66M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IMDX viewer.

Other Companies in Diagnostics & Research

← IMCCAll stocksIMKTA →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.